OUR FIRM

Latest News

July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Ms. Ijem joins Guggenheim from Tourbillon Capital, where she was a healthcare analyst focused on companies across the therapeutics space. Prior to Tourbillon, she was a biotech analyst in the J.P. Morgan Equity Research Healthcare group. Before joining J.P. Morgan, Ms. Ijem was a biotech analyst at Canaccord Genuity. She began her career at Arcoda Capital.

“We are excited to have Whitney join Guggenheim,” said Stefano Natella, Director of Equity Research. “She is a great addition to our healthcare equity research team, and she represents our continued commitment to invest in our healthcare research platform. We look forward to her continued success at Guggenheim.”

In the last 12 months, Guggenheim has significantly expanded its therapeutics research team, which now includes Michael Schmidt, Adnan Butt, Seamus Fernandez, and Etzer Darout.

Ms. Ijem received her M.S. in Biomaterials Science from New York University and her B.S. in Biomedical Engineering from Washington University in St. Louis. She is based in Guggenheim’s New York office.


About Guggenheim Securities

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, Los Angeles, San Francisco, and Houston. For more information, please contact us at GSinfo@GuggenheimPartners.com or 212.518.9200.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $305 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,400 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.


Media Contact

Ellen Cunningham
Guggenheim Partners
212.518.9578
Ellen.N.Cunningham@GuggenheimPartners.com

 

1Assets under management are as of 03.31.2018 and include consulting services for clients whose assets are valued at approximately $66bn. In April 2018, Guggenheim Investments closed the sale of the firm’s Exchange Traded Fund (“ETF”) business representing $38.6bn in assets under management, which will be reflected in the June 30, 2018 assets under management.



July 29, 2021

Seth Sigman Joins Guggenheim Securities as Consumer Internet and eCommerce Analyst

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Seth Sigman has joined the firm as a Managing Director and Research Analyst covering the consumer internet sector with a focus on e-commerce retailers and other digital first consumer product and service companies.

Read More

July 22, 2021

Jonathan Pritti and Andrew Redmond to Join Guggenheim Securities Healthcare Investment Banking

Guggenheim Securities announced today that Jonathan Pritti will join the firm as a Senior Managing Director and Andrew Redmond will join the firm as a Managing Director in its healthcare investment banking practice and will focus on covering healthcare-focused information technology companies.  Messrs. Pritti and Redmond will commence work at Guggenheim in September and will be based out of its New York office.

Read More

July 16, 2021

Guggenheim Securities Wins GlobalCapital’s Esoteric ABS Bank of the Year Award

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today it has been named the “Esoteric ABS Bank of the Year 2020” by capital markets publication GlobalCapital. This recognition follows Guggenheim’s win as “Best Securitization Bank of the Year” award for 2019 and “Most Innovative Securitization Bank of the Year” award for 2018.

Read More